News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Esperion Therapeutics, Inc. to Ring the NASDAQ Stock Market Opening Bell


7/16/2013 9:56:33 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ADVISORY, July 16, 2013 (GLOBE NEWSWIRE) --What: Esperion Therapeutics, Inc. [ESPR], a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of hypercholesterolemia, will visit the NASDAQ MarketSite in Times Square in celebration of its recent IPO and its return to the NASDAQ Stock Market as a publicly traded company which occurred on June 26.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES